# Fluphenazine Decanoate for Psoriasis

> **NCT00356200** · PHASE2 · TERMINATED · sponsor: **Tufts Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Fluphenazine Decanoate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00356200
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2007-12
- **Final completion:** 2008-09
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Enrollment criteria met
- **Last updated:** 2010-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356200, "Fluphenazine Decanoate for Psoriasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00356200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*